Media contributions
1Media contributions
Title Covid care taskforce sees its funding cut Degree of recognition National Media name/outlet The Australian Media type Print Country/Territory Australia Date 16/12/22 Description Australia’s peak evidence advisory group on Covid-19 treatments has had its funding
discontinued, sparking warnings
there will be “critical gaps” in
doctors’ understanding of the
efficacy of continually emerging
therapies.
The National Clinical Evidence Taskforce, a union of 35
member organisations that
includes medical colleges, peak
societies and consumer groups,
was formed at the beginning of
Covid-19 and has been hailed as
“one of the great Australian successes of this pandemic”...
GP Mark Morgan, the cochair of the taskforce’s primary
and chronic care panel, said the
Health Department had indic-
ated the Pharmaceutical Benefits Advisory Committee and the
Therapeutic Goods Administration could take over the job of
analysing new medicines, but the
taskforce’s work went beyond
that and was done speedily.Producer/Author Natasha Robinson URL https://links.streem.com.au/view/the-australian-20221215.pdf?q=cUhPazdpMHJXUDZSQVh3aWdBeWdXNkt0YjhjcXVVajRYMEhsTTMvNUF3TkhQNDdTc3o5SUh5Q0cxWnVsdU1Fc1FVSklNZzQzb1RkNnp2VmM2U3p0QTNZKzB2emNoTUtlZTN2dHgrWjhqSEZqcGRsZ3hhWEtSRm1icW8xS2c2Q0Y3RHBybjRWSmx3NEt4SVdpZXgwRkIxYzlwbDY5V09iZy0tKzRuVVFzS3RqVnB1NVVULy0tV0xhWFRYODJJZm5RVVpPQ2pUb1dvdz09 Persons Mark Morgan